Display options
Cite
Ochs HR, Greenblatt DJ, Burstein ES. Lack of influence of cigarette smoking on triazolam pharmacokinetics. Br J Clin Pharmacol. 1987;23(6):759-63doi: 10.1111/j.1365-2125.1987.tb03112.x.
Ochs, H. R., Greenblatt, D. J., & Burstein, E. S. (1987). Lack of influence of cigarette smoking on triazolam pharmacokinetics. British journal of clinical pharmacology, 23(6), 759-63. https://doi.org/10.1111/j.1365-2125.1987.tb03112.x
Ochs, H R, et al. "Lack of influence of cigarette smoking on triazolam pharmacokinetics." British journal of clinical pharmacology vol. 23,6 (1987): 759-63. doi: https://doi.org/10.1111/j.1365-2125.1987.tb03112.x
Ochs HR, Greenblatt DJ, Burstein ES. Lack of influence of cigarette smoking on triazolam pharmacokinetics. Br J Clin Pharmacol. 1987 Jun;23(6):759-63. doi: 10.1111/j.1365-2125.1987.tb03112.x. PMID: 3606935; PMCID: PMC1386172.
Copy Download .nbib Format: NLM
Share it on
Full text links
Wiley Free PMC Article

Br J Clin Pharmacol. 1987 Jun;23(6):759-63. doi: 10.1111/j.1365-2125.1987.tb03112.x.

Lack of influence of cigarette smoking on triazolam pharmacokinetics.

British journal of clinical pharmacology

H R Ochs, D J Greenblatt, E S Burstein

PMID: 3606935 PMCID: PMC1386172 DOI: 10.1111/j.1365-2125.1987.tb03112.x
Free PMC Article

Abstract

The influence of cigarette smoking on the pharmacokinetics of a single dose of the triazolobenzodiazepine hypnotic triazolam was evaluated in 12 healthy nonsmoking male volunteers and in 12 male subjects, matched for age, height and weight, who smoked an average of 24 cigarettes a day (range: 15-30). Triazolam kinetics were determined from multiple serum concentrations measured during 15 h after a single 0.5 mg dose. There were no significant differences between nonsmoking controls and cigarette smokers in the peak serum triazolam concentration (4.64 vs 4.73 ng ml-1), the time of peak concentration (0.98 vs 1.0 h after dosage), elimination half-life (2.8 vs 2.5 h), or oral clearance of triazolam (506 vs 627 ml min-1). Likewise there were no significant differences between groups in the extent of triazolam binding to serum protein (18.8 vs 18.5% unbound). Altered pharmacodynamics of triazolam in cigarette smokers are not likely to be explained by altered pharmacokinetics.

Similar articles

References

  1. Am J Psychiatry. 1986 Aug;143(8):993-7 - PubMed
  2. J Clin Pharmacol. 1986 Mar;26(3):208-10 - PubMed
  3. J Pharmacokinet Biopharm. 1978 Feb;6(1):7-39 - PubMed
  4. Drug Metab Rev. 1979;9(2):221-36 - PubMed
  5. Clin Pharmacol Ther. 1981 Jan;29(1):81-93 - PubMed
  6. Drugs. 1981 Aug;22(2):81-110 - PubMed
  7. Klin Wochenschr. 1981 Aug 17;59(16):899-903 - PubMed
  8. Br J Psychiatry. 1981 Jul;139:43-6 - PubMed
  9. J Chromatogr. 1981 Sep 11;225(1):202-7 - PubMed
  10. Eur J Clin Pharmacol. 1981;21(3):229-33 - PubMed
  11. Pharmacol Ther. 1981;15(2):207-21 - PubMed
  12. J Pharm Pharmacol. 1983 Mar;35(3):179-80 - PubMed
  13. Br J Clin Pharmacol. 1983 Mar;15(3):303-9 - PubMed
  14. J Clin Psychopharmacol. 1983 Jun;3(3):172-6 - PubMed
  15. Pharmacotherapy. 1983 May-Jun;3(3):137-48 - PubMed
  16. Clin Pharm. 1983 Mar-Apr;2(2):139-43 - PubMed
  17. Br J Clin Pharmacol. 1983 Dec;16(6):743-6 - PubMed
  18. J Clin Psychopharmacol. 1984 Apr;4(2):106-7 - PubMed
  19. Chest. 1985 Feb;87(2):223-6 - PubMed
  20. Klin Wochenschr. 1986 Dec 1;64(23):1217-21 - PubMed

Substances

MeSH terms

Publication Types

Grant support

LinkOut - more resources